Azacitidine in Chronic Myelomonocytic Leukemia: An Effective and Manageable Approach

Azacitidine in Chronic Myelomonocytic Leukemia: An Effective and Manageable Approach

Chronic myelomonocytic leukemia (CMML) is an uncommon neoplastic hematological disorder, typically affecting the elderly, and characterized by a marked clinical heterogeneity and a remarkable propensity for transformation into acute myeloid leukemia. Hypomethylating agents represent the most innovat...

Full description

Bibliographic Details
Main Authors:	Tendas, Andrea, Cupelli, Luca, Siniscalchi, Agostina, Scaramucci, Laura, Giovannini, Marco, Dentamaro, Teresa, Perrotti, Alessio, Caravita, Tommaso, de Fabritiis, Paolo, Niscola, Pasquale
Format:	Online
Language:	English
Published:	Università Cattolica del Sacro Cuore 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965718/

Similar Items

Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia
by: Niscola, Pasquale, et al.
Published: (2015)

Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy
by: Niscola, Pasquale, et al.
Published: (2014)

Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
by: Niscola, Pasquale, et al.
Published: (2013)

Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
by: Niscola, Pasquale, et al.
Published: (2015)

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
by: Tendas, Andrea, et al.
Published: (2016)

Idiopathic thrombocytopenic purpura coexisting with polycythemia vera
by: Niscola, Pasquale, et al.
Published: (2011)

IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome
by: Scaramucci, Laura, et al.
Published: (2012)

Managing myelodysplastic syndromes in very old patients: a teaching case report
by: Niscola, Pasquale, et al.
Published: (2013)

Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin
by: Niscola, Pasquale, et al.
Published: (2012)

Pure erythroid leukemia in advanced breast cancer
by: Niscola, Pasquale, et al.
Published: (2014)

Primary mixed-type autoimmune hemolytic anemia concomitant with acute splanchnic venous thrombosis of idiopathic origin in a young woman: an unexplained association
by: Scaramucci, Laura, et al.
Published: (2013)

Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis
by: Niscola, Pasquale, et al.
Published: (2013)

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia
by: Scaramucci, Laura, et al.
Published: (2013)

Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency
by: Scaramucci, Laura, et al.
Published: (2016)

Authors’ Reply
by: Tendas, Andrea, et al.
Published: (2011)

Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program
by: Tendas, Andrea, et al.
Published: (2011)

Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
by: Niscola, Pasquale, et al.
Published: (2013)

Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
by: Niscola, Pasquale, et al.
Published: (2014)

Pain in Blood Cancers
by: Niscola, Pasquale, et al.
Published: (2011)

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
by: Palombi, Massimiliano, et al.
Published: (2016)

Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report
by: Vischini, Gisella, et al.
Published: (2011)

A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
by: Elli, Elena, et al.
Published: (2012)

A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation
by: Gentile, Giuseppe, et al.
Published: (2006)

Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
by: Niscola, Pasquale, et al.
Published: (2013)

Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease
by: Tendas, A, et al.
Published: (2011)

Primary Pulmonary Hodgkin Lymphoma Simulating a Mediastinal Tumour: an Uncommon Occurrence
by: Fratoni, Stefano, et al.
Published: (2013)

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
by: Stieglitz, Elliot, et al.
Published: (2015)

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
by: Pleyer, Lisa, et al.
Published: (2014)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
by: Liu, Xiaoling, et al.
Published: (2012)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
by: Takita, J, et al.
Published: (2012)

Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma
by: Tschandl, Philipp, et al.
Published: (2012)

Fighting back against chronic myelomonocytic leukemia
by: Jo, Deog-Yeon
Published: (2013)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
by: Chesnais, Virginie, et al.
Published: (2012)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
by: Patnaik, M M, et al.
Published: (2016)

Expressive aphasia in a patient with chronic myelomonocytic leukemia
by: Yeung, Darwin F, et al.
Published: (2014)

A Case of Secondary Leukemia Subsequent to Myelodysplastic Syndromes Successfully Treated with Azacitidine
by: Kumode, Takahiro, et al.
Published: (2014)

Azacitidine as Salvage Therapy for Acute Myeloid Leukemia in a Severely Ill Patient
by: Powers, Harry Ross, et al.
Published: (2014)

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
by: Niemeyer, Charlotte M., et al.
Published: (2010)

5-Azacytidine in Chronic Myelomonocytic Leukemia: Case Report and Review of Literature.
by: Greco, M., et al.
Published: (2011)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
by: Rohon, Peter, et al.
Published: (2012)